DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Global Biomarkers Market Analysis & Trends - Industry Forecast to 2025" report to their offering.
The Global Biomarkers Market is poised to grow at a CAGR of around 14.4% over the next decade to reach approximately $92.5 billion by 2025.
This industry report analyzes the global markets for Biomarkers across all the given segments on global as well as regional levels presented in the research scope. The study provides historical market data for 2013, 2014 revenue estimations are presented for 2015 and forecasts from 2016 till 2025.
The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. With comprehensive market assessment across the major geographies such as North America, Europe, Asia Pacific, Middle East, Latin America and Rest of the world the report is a valuable asset for the existing players, new entrants and the future investors.
The market data is gathered from extensive primary interviews and secondary research. The market size is calculated based on the revenue generated through sales from all the given segments and sub segments in the research scope. The market sizing analysis includes both top-down and bottom-up approaches for data validation and accuracy measures.
- Abbott Laboratories
- Agilent Technologies Inc.
- Becton, Dickinson and Company.
- Bio-Rad Laboratories, Inc.
- Biomerieux S.A.
- Biosims Technologies
- Celera Corporation
- DiagnoCure Inc.
- Epigenomics AG
- GE Healthcare
- Merck & Co, Inc.
- Roche Diagnostics
- Siemens Healthcare
- Singulex, Inc.
- Thermo Fisher Scientific, Inc.
1 Market Outline
2 Executive Summary
3 Market Overview
4 Biomarkers Market, By Disease Indication
5 Biomarkers Market, By Type
6 Biomarkers Market, By Product
7 Biomarkers Market, By Application
8 Biomarkers Market, By Geography
9 Leading Companies
For more information visit http://www.researchandmarkets.com/research/xvbgp5/global_biomarkers